Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1458)
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
54
Price
$168.43
Total Value
$9.10K
Shares Held After
9,687
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
373
Price
$167.37
Total Value
$62.43K
Shares Held After
9,741
% of Holdings
3.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
127
Price
$166.56
Total Value
$21.15K
Shares Held After
10,114
% of Holdings
1.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
158
Price
$165.38
Total Value
$26.13K
Shares Held After
10,241
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
267
Price
$164.47
Total Value
$43.91K
Shares Held After
10,399
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$576.62
Total Value
$69.19K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
535
Price
$574.79
Total Value
$307.51K
Shares Held After
19,360
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
321
Price
$573.51
Total Value
$184.10K
Shares Held After
19,895
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,976
Price
$572.66
Total Value
$2.28M
Shares Held After
20,216
% of Holdings
16.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,325
Price
$571.64
Total Value
$1.90M
Shares Held After
24,192
% of Holdings
12.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,079
Price
$570.82
Total Value
$615.91K
Shares Held After
27,517
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
280
Price
$569.63
Total Value
$159.50K
Shares Held After
28,596
% of Holdings
1.0%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
388,067
% of Holdings
0.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
56,450
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
156,869
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
66,083
% of Holdings
0.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.90
Total Value
$49.00K
Shares Held After
3,052,000
% of Holdings
0.3%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
421
Price
$54.56
Total Value
$22.97K
Shares Held After
95,880
% of Holdings
0.4%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
6,619
Price
$54.07
Total Value
$357.86K
Shares Held After
96,301
% of Holdings
6.4%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Apel Daniel Joseph — Chief Financial Officer
Shares
8,730
Price
$71.92
Total Value
$627.86K
Shares Held After
162,905
% of Holdings
5.1%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Apel Daniel Joseph — Chief Financial Officer
Shares
1,157
Price
$70.45
Total Value
$81.51K
Shares Held After
171,635
% of Holdings
0.7%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Apel Daniel Joseph — Chief Financial Officer
Shares
3,208
Price
$70.11
Total Value
$224.91K
Shares Held After
172,792
% of Holdings
1.8%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
165,150
Price
$15.77
Total Value
$2.60M
Shares Held After
2,402,095
% of Holdings
6.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.13
Total Value
$269.32K
Shares Held After
390,808
% of Holdings
4.7%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
300
Price
$90.00
Total Value
$27.00K
Shares Held After
61,202
% of Holdings
0.5%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.61
Total Value
$144.40K
Shares Held After
906,556
% of Holdings
4.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12
Price
$90.08
Total Value
$1.08K
Shares Held After
674,944
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
88
Price
$90.08
Total Value
$7.93K
Shares Held After
3,899,829
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,900
Price
$89.96
Total Value
$530.76K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
364
Price
$575.85
Total Value
$209.61K
Shares Held After
18,996
% of Holdings
1.9%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
7,000
Price
$30.05
Total Value
$210.38K
Shares Held After
388,167
% of Holdings
1.8%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
7,000
Price
$30.05
Total Value
$210.36K
Shares Held After
156,969
% of Holdings
4.3%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
7,000
Price
$30.05
Total Value
$210.36K
Shares Held After
56,450
% of Holdings
11.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
500
Price
$30.00
Total Value
$15.00K
Shares Held After
56,450
% of Holdings
0.9%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
7,001
Price
$30.05
Total Value
$210.40K
Shares Held After
66,083
% of Holdings
9.6%
ProMIS Neurosciences Inc. (PMN)
Kirwin Patrick D. — Director
Shares
4,000
Price
$11.33
Total Value
$45.32K
Shares Held After
4,653
% of Holdings
86.0%
Axsome Therapeutics, Inc. (AXSM)
Maizel Ari — Chief Commercial Officer
Shares
7,500
Price
$182.42
Total Value
$1.37M
Shares Held After
0
% of Holdings
100.0%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
7,040
Price
$54.29
Total Value
$382.18K
Shares Held After
102,920
% of Holdings
6.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$580.06
Total Value
$348.03K
Shares Held After
40,513
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,099
Price
$579.08
Total Value
$636.41K
Shares Held After
41,113
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,781
Price
$578.11
Total Value
$1.03M
Shares Held After
42,212
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,707
Price
$576.98
Total Value
$984.91K
Shares Held After
43,993
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,410
Price
$575.99
Total Value
$812.15K
Shares Held After
45,700
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
736
Price
$574.86
Total Value
$423.09K
Shares Held After
47,110
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,644
Price
$574.06
Total Value
$943.75K
Shares Held After
47,846
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
523
Price
$572.48
Total Value
$299.41K
Shares Held After
49,490
% of Holdings
1.0%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
9,100
Price
$39.09
Total Value
$355.72K
Shares Held After
113,987
% of Holdings
7.4%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
151
Price
$66.00
Total Value
$9.97K
Shares Held After
858,887
% of Holdings
0.0%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
7,910
Price
$65.28
Total Value
$516.33K
Shares Held After
859,038
% of Holdings
0.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
21
Price
$173.04
Total Value
$3.63K
Shares Held After
10,666
% of Holdings
0.2%
Showing 101–150 of 1458 transactions (page 3 of 30)